saquinavir
Selected indexed studies
- Saquinavir: From HIV to COVID-19 and Cancer Treatment. (Biomolecules, 2022) [PMID:35883499]
- Saquinavir. (J Assoc Nurses AIDS Care, 1996) [PMID:8875367]
- Saquinavir. Clinical pharmacology and efficacy. (Clin Pharmacokinet, 1998) [PMID:9533981]
_Worker-drafted node — pending editorial review._
Connections
saquinavir is a side effect of
Sources
- Saquinavir: From HIV to COVID-19 and Cancer Treatment. (2022) pubmed
- Saquinavir. (1996) pubmed
- Saquinavir. Clinical pharmacology and efficacy. (1998) pubmed
- Saquinavir, the pioneer antiretroviral protease inhibitor. (2009) pubmed
- Saquinavir soft gelatin capsule: a comparative safety review. (2001) pubmed
- Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection. (2000) pubmed
- Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection. (1996) pubmed
- Saquinavir: a review of its use in boosted regimens for treating HIV infection. (2003) pubmed
- Saquinavir soft-gel capsule formulation. A review of its use in patients with HIV infection. (1998) pubmed
- Deciphering Saquinavir-Bovine Serum Albumin Interactions: Spectroscopic and Computational Insights. (2025) pubmed